通过对现有全球议程进行战略协调,可以改善拉丁美洲和加勒比癌症儿童的免疫接种覆盖率。

IF 3.5 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Human Vaccines & Immunotherapeutics Pub Date : 2025-12-01 Epub Date: 2025-05-26 DOI:10.1080/21645515.2025.2509472
Maysam R Homsi, Carol Underwood, Miguela A Caniza, Melissa A Davey-Rothwell
{"title":"通过对现有全球议程进行战略协调,可以改善拉丁美洲和加勒比癌症儿童的免疫接种覆盖率。","authors":"Maysam R Homsi, Carol Underwood, Miguela A Caniza, Melissa A Davey-Rothwell","doi":"10.1080/21645515.2025.2509472","DOIUrl":null,"url":null,"abstract":"<p><p>Most cases of childhood cancer occur in low- and middle-income countries. In parallel, children with cancer are more vulnerable to infections, including vaccine-preventable infections. We distributed an electronic, self-administered survey to healthcare providers working in Latin America and the Caribbean region who deliver care to children with cancer to assess the factors that influence their decision and ability to vaccinate children with cancer. Our study found that approximately half of respondents consistently requested the patient's vaccination record before starting cancer treatment and that less than 20% estimated that ≥75% of their pediatric patients were up to date on their immunizations. Only a small fraction reported having related government policies and reporting requirements for immunizing/re-immunizing children with cancer. Respondents recognize the need to immunize children with cancer; however, national policies and monitoring tools for this population are lacking. There are global initiatives to address gaps in immunization coverage and to promote the development of policy and infrastructure to support the increasing number of children with cancer. Although they have clear and distinct goals, there are opportunities to combine efforts. Integrating immunizations into national childhood cancer treatment policies and enhancing current vaccination surveillance platforms can address gaps and support an overlooked population.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"21 1","pages":"2509472"},"PeriodicalIF":3.5000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12118396/pdf/","citationCount":"0","resultStr":"{\"title\":\"Immunization coverage for children with cancer in Latin America and the Caribbean can be improved through strategic coordination of existing global agendas.\",\"authors\":\"Maysam R Homsi, Carol Underwood, Miguela A Caniza, Melissa A Davey-Rothwell\",\"doi\":\"10.1080/21645515.2025.2509472\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Most cases of childhood cancer occur in low- and middle-income countries. In parallel, children with cancer are more vulnerable to infections, including vaccine-preventable infections. We distributed an electronic, self-administered survey to healthcare providers working in Latin America and the Caribbean region who deliver care to children with cancer to assess the factors that influence their decision and ability to vaccinate children with cancer. Our study found that approximately half of respondents consistently requested the patient's vaccination record before starting cancer treatment and that less than 20% estimated that ≥75% of their pediatric patients were up to date on their immunizations. Only a small fraction reported having related government policies and reporting requirements for immunizing/re-immunizing children with cancer. Respondents recognize the need to immunize children with cancer; however, national policies and monitoring tools for this population are lacking. There are global initiatives to address gaps in immunization coverage and to promote the development of policy and infrastructure to support the increasing number of children with cancer. Although they have clear and distinct goals, there are opportunities to combine efforts. Integrating immunizations into national childhood cancer treatment policies and enhancing current vaccination surveillance platforms can address gaps and support an overlooked population.</p>\",\"PeriodicalId\":49067,\"journal\":{\"name\":\"Human Vaccines & Immunotherapeutics\",\"volume\":\"21 1\",\"pages\":\"2509472\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12118396/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Human Vaccines & Immunotherapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/21645515.2025.2509472\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2025.2509472","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

大多数儿童癌症病例发生在低收入和中等收入国家。与此同时,患有癌症的儿童更容易受到感染,包括疫苗可预防的感染。我们向拉丁美洲和加勒比地区为癌症儿童提供护理的医疗保健提供者分发了一份自我管理的电子调查,以评估影响他们为癌症儿童接种疫苗的决定和能力的因素。我们的研究发现,大约一半的受访者在开始癌症治疗前一直要求患者提供疫苗接种记录,不到20%的受访者估计,他们的儿科患者中有≥75%的人进行了最新的免疫接种。只有一小部分报告说,政府制定了对癌症儿童进行免疫接种/再免疫接种的相关政策和报告要求。答复者认识到需要对患癌症的儿童进行免疫接种;然而,缺乏针对这一人群的国家政策和监测工具。现已采取全球行动,解决免疫覆盖方面的差距,并促进制定政策和基础设施,以支持越来越多的癌症儿童。虽然他们有明确和不同的目标,但有机会共同努力。将免疫纳入国家儿童癌症治疗政策并加强目前的疫苗接种监测平台,可以解决差距并支持被忽视的人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Immunization coverage for children with cancer in Latin America and the Caribbean can be improved through strategic coordination of existing global agendas.

Immunization coverage for children with cancer in Latin America and the Caribbean can be improved through strategic coordination of existing global agendas.

Most cases of childhood cancer occur in low- and middle-income countries. In parallel, children with cancer are more vulnerable to infections, including vaccine-preventable infections. We distributed an electronic, self-administered survey to healthcare providers working in Latin America and the Caribbean region who deliver care to children with cancer to assess the factors that influence their decision and ability to vaccinate children with cancer. Our study found that approximately half of respondents consistently requested the patient's vaccination record before starting cancer treatment and that less than 20% estimated that ≥75% of their pediatric patients were up to date on their immunizations. Only a small fraction reported having related government policies and reporting requirements for immunizing/re-immunizing children with cancer. Respondents recognize the need to immunize children with cancer; however, national policies and monitoring tools for this population are lacking. There are global initiatives to address gaps in immunization coverage and to promote the development of policy and infrastructure to support the increasing number of children with cancer. Although they have clear and distinct goals, there are opportunities to combine efforts. Integrating immunizations into national childhood cancer treatment policies and enhancing current vaccination surveillance platforms can address gaps and support an overlooked population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY
CiteScore
7.90
自引率
8.30%
发文量
489
审稿时长
3-6 weeks
期刊介绍: (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信